Trans carotenoids, their synthesis, formulation and uses

Details Trans carotenoids, their synthesis, formulation and uses Trans carotenoids, their synthesis, formulation and uses

2006-02-24

2011-10-04

Carr, Deborah D (Department: 1621)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

C554S121000

Reexamination Certificate

active

08030350

ABSTRACT:
The invention relates to trans carotenoid compounds and salts thereof as well as compositions thereof, methods for making them, and uses thereof. These compounds are useful in improving diffusivity of oxygen between red blood cells and body tissues in mammals including humans.

REFERENCES:
patent: 2175843 (1939-10-01), Kuhn et al.
patent: 2948748 (1960-08-01), Guex et al.
patent: 3489806 (1970-01-01), Gutmann et al.
patent: 3687990 (1972-08-01), Gutmann et al.
patent: 3788468 (1974-01-01), Gainer
patent: 3853933 (1974-12-01), Siciliano
patent: 3853993 (1974-12-01), Gainer
patent: 3965261 (1976-06-01), Gainer
patent: 3975519 (1976-08-01), Gainer
patent: 4009270 (1977-02-01), Gainer, Jr.
patent: 4038144 (1977-07-01), Gainer
patent: 4046880 (1977-09-01), Gainer
patent: 4070460 (1978-01-01), Gainer, Jr.
patent: 4099270 (1978-07-01), Jabour
patent: 4105855 (1978-08-01), Schulz et al.
patent: 4176179 (1979-11-01), Gainer
patent: 4216211 (1980-08-01), Francis
patent: 4727064 (1988-02-01), Pitha
patent: 5053240 (1991-10-01), Todd, Jr.
patent: 5107030 (1992-04-01), Babler
patent: 5424407 (1995-06-01), Tanaka et al.
patent: 5472946 (1995-12-01), Peck et al.
patent: 5811119 (1998-09-01), Mehta et al.
patent: 6060511 (2000-05-01), Gainer
patent: 6150561 (2000-11-01), Kreienbuhl et al.
patent: 7145025 (2006-12-01), Lockwood
patent: 7446101 (2008-11-01), Madhavi et al.
patent: 2003/0180282 (2003-09-01), Serebruany et al.
patent: 2004/0109920 (2004-06-01), Reuscher et al.
patent: 2006/0194973 (2006-08-01), Gainer et al.
patent: 2007/0088248 (2007-04-01), Glenn et al.
patent: 2008/0255246 (2008-10-01), Gainer
patent: 522 572 (1972-06-01), None
patent: 0 908 449 (1999-04-01), None
patent: 0 908 449 (1999-04-01), None
patent: 45-14114 (1970-05-01), None
patent: 61-254161 (1986-11-01), None
patent: 63-59831 (1988-03-01), None
patent: 63-059831 (1988-03-01), None
patent: 63059831 (1988-03-01), None
patent: A 03-056412 (1991-03-01), None
patent: A 04-264020 (1992-09-01), None
patent: 05-032531 (1993-02-01), None
patent: 05032531 (1993-02-01), None
patent: A 05-178765 (1993-07-01), None
patent: 06-248193 (1994-09-01), None
patent: 07-023736 (1995-01-01), None
patent: 7-223960 (1995-08-01), None
patent: A 07/291854 (1995-11-01), None
patent: 10-502388 (1998-03-01), None
patent: 11-180901 (1999-06-01), None
patent: 11-209642 (1999-08-01), None
patent: 2002-524535 (2002-08-01), None
patent: A 03-26607 (2003-01-01), None
patent: 2005-518453 (2005-06-01), None
patent: 1999-0036861 (1999-05-01), None
patent: WO 92/15544 (1992-09-01), None
patent: WO 9215544 (1992-09-01), None
patent: WO 9500130 (1995-01-01), None
patent: WO 98/14183 (1998-04-01), None
patent: WO 9814183 (1998-04-01), None
patent: WO 99/15150 (1999-04-01), None
patent: WO 03/072734 (2003-09-01), None
patent: WO 03/072734 (2003-09-01), None
patent: WO 03072734 (2003-09-01), None
patent: WO 2004/048323 (2004-06-01), None
patent: WO 2005/028411 (2005-03-01), None
patent: WO 2006/039685 (2006-04-01), None
patent: WO 2006/104610 (2006-10-01), None
patent: WO 2006/104610 (2006-10-01), None
patent: WO 2007/072529 (2007-06-01), None
Database HCAPLUS on STN, DN 141:388250, Magesh, V. “Studies on the anti-tumor effect of crocetin against 3enzo(a)pyrene induced lung cancer in Swiss albino mice.” Biomedicine, (Chennai, India) (2003), 23 (3 & 4), 96-99,Abstract.
Chem. Abstr. of JP 05032531.
Office Action dated Aug. 24, 2007 from U.S. Appl. No. 11/790,779.
International Preliminary Report on Patentability (Chapter 1 of the Patent Cooperation Treaty) with written opinion mailed Oct. 19, 2006 in PCT/US06/06422.
Database HCAPLUS on STN, DN 141:388250, Magesh, V. “Studies on the anti-tumor effect of crocetin against benzo(a)pyrene induced lung cancer in Swiss albino mice.” Biomedicine, (Chennai, India) (2003), 23 (3 & 4), 96-99, Abstract.
International Preliminary Examination Report dated May 25, 2007.
Supplementary Partial European Search Report dated Nov. 7, 2006.
International Search Report mailed Oct. 19, 2006 in PCT/US06/06422.
Written Opinion mailed Oct. 19, 2006 in PCT/US06/06422.
Office Action dated Sep. 28, 2007 from U.S. Appl. No. 11/723,383.
International Search Report and Written Opinion mailed Jul. 22, 2008.
Gainer, J.L., et al,Atherosclerosis, 19: 135-138, 1974, “Oxygen diffusion and atherosclerosis.”
Craw, M., et al,Photochemitry and Photobiology, vol. 38 (2), 241-243 (1983).
U.S. Appl. No. 10/647,132, filed Aug. 2003, Gainer.
U.S. Appl. No. 11/361,054, filed Feb. 2006, Gainer.
Examination Report dated Jan. 8, 2008 from corresponding New Zealand Patent Office.
Chinese Office Action dated Nov. 7, 2008 in a corresponding application owned by the applicants (Chinese App No. 03826969.4).
Laidig, K.E. et al, Altering Diffusivity in Biological Solutions through Modification of Solution Structure and Dynamics,Journal of the American Chemical Society, 1998, vol. 120, No. 36, pp. 9394-9395.
India Office Action dated Oct. 23, 2008 in a corresponding application owned by the applicants (India Patent App No. 676/DELNP/2006).
Examination Report dated Oct. 6, 2008 issued by the New Zealand Patent Office in one of Applicants' corresponding foreign applications.
Chinese Patent Office—Third Office Action in Chinese Patent Application No. 03804566.4 dated Jan. 23, 2009.
International Searching Authority Invitation dated Jan. 13, 2009 in PCT/US 08/12440.
Johnson, Mark E, et al,Journal of Pharmaceutical Sciences, vol. 85, No. 7, Jul. 1996, pp. 670-679, entitled “Synergistic Effects of Chemical Enhancers and Therapeutic Ultrasound on Transdermal Drug Delivery.”
PCT Notification dated Mar. 25, 2009 in PCT/US 08/12440.
International Search Report dated Mar. 25, 2009 in PCT/US 08/12440.
Written Opinion dated Mar. 25, 2009 in PCT/US 08/12440.
Johnson, M.E., et al,Journal of Pharmaceutical Sciences, vol. 85, No. 7, pp. 670-679, Jul. 1996, “Synergistic effects of chemical enhancers and therapeutic ultrasound on transdermal drug delivery.”
Mexican Office Action dated Feb. 23, 2009 in a corresponding application owned by the applicants (Mexican Patent App No. PA/a/2004/008253).
Moelbert, S., et al,Biophuysical Chemistry112, 45-57, 2004 “Kosmotropes and chaotropes: modeling preferential exclusion, binding and aggregate stability.”
Gainer, J.L., et al,Chem. Eng. Commun., 15, pp. 323-329, 1982 “Using Excess Volume of Mixing to Correlate Diffusivities in Liquids.”
Gainer, J.L.,Ind. Engr. Chem. Research, vol. 33, pp. 2341-2344, 1994 “Altering Diffusivities in Dilute Polymeric and Biological Solutions.”
Okonkwo, D.O., et al,Neuroscience Letters, 352, pp. 97-100, 2003, “Trans-sodium crocetinate increases oxygen delivery to brain Parenchyma in rats on oxygen supplementation.”
Giassi, L.J., et al,Journal of Trauma, 51:932-938, 2001, “Trans Sodium Crocetinate Restores Blood Pressure, Heart Rate, and Plasma Lactate after Hemorrhagic Shock.”
Gainer, J.L., et al,Pulmonary Pharmacology&Therapeutics, 18, pp. 213-216, 2005, “The effect of trans sodium crocetinate (TSC) in a rat oleic acid model of acute lung injury.”
Holland, R.A.B., et al,Respiration Physiology, 59, pp. 71-91, 1985, “Kinetics of O2 Uptake and Release by Red Cells in Stopped-Flow Apparatus: Effects of unstirred Layer.”
Huxley, V.H., et al,J. Physiol., 316, pp. 75-83, 1981, “The Effect of the Red Cell Membrane and a Diffusion Boundary Layer on the Rate of Oxygen Uptake by Human Erythrocytes.”
Yamaguchi, K., et al,J. Applied Physiology, 58: 1215-1224, 1985.
Laidig, K. E., et al,Journal of the American Chemical Society, vol. 120, No. 36, pp. 9394-9395, 1998, “Altering Diffusivity in Biological Solutions through Modification of Solution Structure and Dynamics.”
Stennett, A.K., et al,J. Phys. Chem. B., vol. 110, No. 37, pp. 18078-18080, 2006, “trans-Sodium Crocetinate and Diffusion Enhancement.”
Secor, R.M.,A.I.Ch.E. Journal, vol. 11, No. 3, pp. 452-456, 1965, “The Effect of Concentration

Affiliated with

Also associated with

Rating

Trans carotenoids, their synthesis, formulation and uses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Trans carotenoids, their synthesis, formulation and uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trans carotenoids, their synthesis, formulation and uses will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4294497